tradingkey.logo
tradingkey.logo
Suchen

Boston Scientific Corp

BSX
Zur Watchlist hinzufügen
44.205USD
-0.255-0.57%
Handelsschluss 06/25, 16:00ETKurse um 15 Minuten verzögert
65.70BMarktkapitalisierung
18.39KGV TTM

mehr Informationen über Boston Scientific Corp Unternehmen

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Boston Scientific Corp Informationen

BörsenkürzelBSX
Name des UnternehmensBoston Scientific Corp
IPO-datumMay 19, 1992
CEOMahoney (Michael F)
Anzahl der mitarbeiter53000
WertpapierartOrdinary Share
GeschäftsjahresendeMay 19
Addresse300 Boston Scientific Way
StadtMARLBOROUGH
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl01752-1234
Telefon15086834000
Websitehttps://www.bostonscientific.com/en-US/Home.html
BörsenkürzelBSX
IPO-datumMay 19, 1992
CEOMahoney (Michael F)

Führungskräfte von Boston Scientific Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
45.38K
+8.37%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
13.88K
+59.45%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
--
Mr. Joseph M. Fitzgerald
Mr. Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiology
Executive Vice President, Group President - Cardiology
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
45.38K
+8.37%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Boston Scientific Corp?

Die fünf größten Anteilseigner von Boston Scientific Corp sind: Mr. Michael F. (Mike) Mahoney

Wie viele Institutionen halten Anteile an Boston Scientific Corp (BSX)?

Mit Stand vom 2026Q1 halten 3113 Institutionen Anteile an Boston Scientific Corp, mit einem Gesamtmarktwert von etwa 1.40B, was 94.35% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -15512534.00 gestiegen.

Was ist die größte Einnahmequelle von Boston Scientific Corp?

Am 2026Q1 erzielte das Geschäft mit Interventional Cardiology Therapies für Boston Scientific Corp den höchsten Umsatz in Höhe von 4.64B, was 23.11% des Gesamtumsatzes entspricht.
KeyAI